- Home
- ADXN vs ICU Comparison
ADXN vs ICU Comparison
Compare ADXN & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- ICU
- Stock Information
- Founded
- ADXN 2002
- ICU 2018
- Country
- ADXN Switzerland
- ICU United States
- Employees
- ADXN N/A
- ICU N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- ADXN Health Care
- ICU Health Care
- Exchange
- ADXN Nasdaq
- ICU Nasdaq
- Market Cap
- ADXN 8.0M
- ICU 8.9M
- IPO Year
- ADXN N/A
- ICU N/A
- Fundamental
- Price
- ADXN $7.97
- ICU $1.75
- Analyst Decision
- ADXN Strong Buy
- ICU
- Analyst Count
- ADXN 1
- ICU 0
- Target Price
- ADXN $30.00
- ICU N/A
- AVG Volume (30 Days)
- ADXN 25.1K
- ICU 24.8K
- Earning Date
- ADXN 11-22-2024
- ICU 11-13-2024
- Dividend Yield
- ADXN N/A
- ICU N/A
- EPS Growth
- ADXN N/A
- ICU N/A
- EPS
- ADXN 0.06
- ICU N/A
- Revenue
- ADXN $701,260.00
- ICU $68,000.00
- Revenue This Year
- ADXN N/A
- ICU N/A
- Revenue Next Year
- ADXN N/A
- ICU $358.72
- P/E Ratio
- ADXN $1.03
- ICU N/A
- Revenue Growth
- ADXN N/A
- ICU N/A
- 52 Week Low
- ADXN $6.45
- ICU $1.68
- 52 Week High
- ADXN $27.90
- ICU $42.93
- Technical
- Relative Strength Index (RSI)
- ADXN 50.40
- ICU 34.18
- Support Level
- ADXN $7.28
- ICU $1.68
- Resistance Level
- ADXN $8.36
- ICU $2.01
- Average True Range (ATR)
- ADXN 0.74
- ICU 0.13
- MACD
- ADXN 0.05
- ICU -0.01
- Stochastic Oscillator
- ADXN 50.26
- ICU 14.00
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.